An orthorhombic polymorph of isavuconazole
The title compound C<sub>22</sub>H<sub>17</sub>F<sub>2</sub>N<sub>5</sub>OS (systematic name: 4-{2-[(2<i>R</i>,3<i>R</i>)-3-(2,5-di-fluoro-phen-yl)-3-hy-droxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thia-zol-4-yl}benzo-nitrile), represents a new ortho-rhom-bic polymorph of isavuconazole. The two stereogenic centers adopt the <i>R</i>,<i>R</i> configuration. In the crystal structure of the ortho-rhom-bic form, a mono-periodic chain motif is formed by a strong O-H⋯N hydrogen bond, while three additional C-H⋯N inter-actions propagate these chains into a tri-periodic supra-molecular network. A comparison with the previously reported monoclinic polymorph [Voronin <i>et al.</i> (2021 ▸). <i>CrystEngComm</i> <b>23</b>, 8513] is provided, supported by Hirshfeld surface and energy framework analyses.
Authors
- Lilianna Chęcińska (ORCID: https://orcid.org/0000-0002-3546-920X)
- Anna Ben
Institutions
- University of Łódź (PL)
- Exact Sciences (United States) (US)
Publication Details
- Journal
- Acta Crystallographica Section E Crystallographic Communications
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1107/s2056989025008886
- Primary Topic
- Cancer therapeutics and mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00